Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Vulvar Squamous Cell Carcinoma - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Vulvar Squamous Cell ... Read More
-
Thyroid Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Thyroid Cancer Understanding The DelveInsight Thyroid Cancer ... Read More
-
Advanced Recurrent Ovarian Cancer - Epidemiology Forecast to 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Advanced Recurrent Ovarian ... Read More
-
Gastric Cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Gastric Cancer Understanding The DelveInsight Gastric Cancer ... Read More
-
Liver cancer - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Liver cancer Understanding The DelveInsight Liver cancer ... Read More
-
Mesothelioma - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Mesothelioma Understanding The DelveInsight Mesothelioma epidemiology report gives a ... Read More
-
Cancer Pain - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Cancer Pain Understanding The DelveInsight Cancer Pain ... Read More
-
HER+ Gastric Cancer - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 HER+ Gastric Cancer Understanding The ... Read More
-
Malignant Pleural Mesothelioma - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Malignant Pleural Mesothelioma Understanding The ... Read More
-
The World Market for Cancer Diagnostics, 2021
... cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity ... Read More
-
At-Home Testing: COVID-19 Trends and Future Potential
... disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This report covers trends that have occurred since the pandemic was declared in 2020 to the recent present – March 31, 2021. ... Read More
-
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors, Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT) & IDO Inhibitors
... (ACT) & IDO Inhibitors Within the cancer therapeutics space, which today is worth over $160 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for ... Read More
-
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities
... in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)
... a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years ... Read More
-
Molecular Cancer Diagnostics Market
... leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular ... Read More
-
CAR-T Cell Therapy Market Review
... that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a ... Read More
-
Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool
... interest and a growing list of stakeholders operating in this field. Users of this report get an un-biased, fact driven analysis of the position of each molecule and commercial player, always kept up to date ... Read More
-
The Worldwide Market for Targeted Cancer Therapeutics
... Targeted Cancer Therapeutics focuses on the expanding area of targeted therapies and includes current products available and discusses some of the most exciting developments in progress. This report covers targeted cancer therapies that do at ... Read More
-
The Worldwide Market for Point-of-Care (POC) Diagnostics (Infectious Disease, Colon Cancer, Rapid Coagulation, Urine, Lipid, Pregnancy, Glucose and Other POC)
... POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has ... Read More
-
World Market for Precision Cancer Diagnostic Tests
... also used in cancer staging as well as in the selection, monitoring, and assessment of prescribed oncological therapies. World Market for Precision Cancer Diagnostic Tests, a market-based and industry-focused report, examines the global market environment ... Read More
-
Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others)
... provides a complete global revenue summary, including the total global market for preventive vaccines by type for 2015 to 2024 (pediatric total: combinations, hepatitis, haemophilus influenzae type B, measles, mumps and rubella, pneumococcal, poliovirus, varicella, ... Read More
-
Cancer Liquid Biopsy Market Assessment
... the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in the diagnosis of solid cancers, but despite their widespread use, they have many limitations that ... Read More
-
World Prescription Dermatological Drugs Market, 10th Edition (Antiacne & Rosacea, Antiaging & Photodamage, Dermatitis & Seborrhea, Antifungal, Hair Loss & Hair Removal, Hyperpigmentation/Melasma & Depigmenting, Psoriasis, and Skin Cancer Drug Market)
... Prescription Dermatological Drugs Market details the various categories of prescription dermatological drugs, describes the worldwide market for prescription dermatological drugs, and identifies major market factors that may help to shape the worldwide market for prescription ... Read More
-
Potential "Pipeline Disruptors" - New Products That Will Drive The Future Pharmaceutical Market
... six areas are expected to show the strongest pipeline impact and candidates are likely to replace current therapies. The market is evaluated for 2015 and 2016 with forecast data provided through 2022. Forecast data were ... Read More
-
World Personalized Medicine Tests for Cancer
... North America, the European Union, and the rest of the world. To illustrate historical trends world demand (including regional segments) is provided for 2016. A World Overview and Forecasts section provides pertinent topical background, including ... Read More
Research Assistance
